Click here to visit our dedicated Entitlement Offer (NREO) page for all the information you need to participate.

Innovating the way we see and treat cancer

Innovating the way we see and treat cancer

VIDEO

Radiopharm Theranostics panel discusses latest progress and understanding of radiopharmaceutical sector

LATEST NEWS

Sign up to Investor Hub to get all the latest news and ASX Announcements direct to your inbox

We are focused on the development of radiopharmaceutical products for diagnostic and therapeutic uses in areas of high unmet medical need.

Our technology

The unique potential of Radiopharmaceuticals in treating oncological diseases.

Our pipeline

The unique potential of being First to Market or Best in Class.

Our team

We have a unique commitment to improve patients’ hope in fighting cancer.

Information for investors

Stock price, Company governance & updates from our multiple development programs.

Sign up to our mailing list.

Receive all the latest news from Radiopharm Theranostics.